CBI Scene Blog

Colette Thorold

Colette Thorold, Associate Product Manager, Patient Technology Solutions, PAREXEL Colette currently works in the Product Management group for PAREXEL focusing on the ClinPhone® RTSM product. In this role, she uses market research and industry analysis to understand the end user’s goals and needs and then defines solutions to meet them. Colette has an extensive education in Mathematics from The University of Oxford specializing in its medical applications. She also achieved a Distinction in MSC Mathematical Medicine and Biology at Nottingham University in 2015 and has completed the PAREXEL Academy Postgraduate Certificate in Clinical Trial Management.

Recent Posts

How to Know You’re Keeping Your (Clinical Trial Supplies) Cool

Posted by Colette Thorold on Oct 11, 2017 9:26:10 AM

Today, nearly 40 percent of all healthcare products are temperature sensitive (1). It is expected that eight of the top ten global biopharmaceutical products will require cold chain handling by 2020 (2). These sensitive products must be stored within a limited temperature range until their expiration dates to ensure they retain their effectiveness. Furthermore, many products, including those stored at room temperature (from 15°C to 25°C/60°F to 75°F), may require temperature monitoring as well, driven by stricter regulatory guidelines.

Traditional methods for shipment temperature monitoring involve USB or similar loggers which require the site staff to plug in the USB, download the PDF, upload or manually enter into the RTSM (Randomization and Trial Supply Management), also known as IRT (Interactive Response Technology) system. Site users must then email the CRA before the kit/shipment can be marked as damaged/quarantined/available. Multiple issues arise from this approach:

      • Time spent on manual logger processing could mean less time for site staff to spend with patients
      • Sponsors are finding site enrolment is increasingly competitive and sites prefer sponsors who “make their lives easier” by improving the arrivals process
      • Lack of visibility of temperature excursions means less assurance of safety of medication
      • Multiple temperature monitoring options (loggers, fridges etc.) and lack of integration between them causes delays and data errors
      • The temperature logging often ends upon shipment arrival, leaving gaps in monitoring (this is often due to the logger being associated to a complete shipment not an individual pack/kit)
      • Shipments/packs can be quarantined for a long time due to uncertainty around safety and the length of time to investigate the temperature excursion(s)
      • It is only upon arrival at site that excursions are discovered, increasing the risk that a patient attends a visit and cannot receive medication due to quarantine

It's difficult to get an aggregated view of temperature data throughout the entire ‘supply chain of custody’ – from the point of packaging to dispensation to the patient. Applying Mobile and Cloud Technologies to Temperature Management and RTSM Integration Read More

Topics: Clinical